UK-based molecular diagnostics company Biofortuna has appointed a new chairman to lead the next phase of growth. Life sciences expert Ian Johnson will take on the role at Biofortuna, with previous chairman Mark Hurley remaining on the board as a non-executive director.
Biofortuna, based in the Wirral, specialises in proprietary freeze-dried diagnostics and contract services. It recently announced a £1.5 million funding round to develop its diagnostic assays and invest in its freeze drying production capability.
Mark Hurley said: “Over the years I have thoroughly enjoyed being chairman and seeing the company grow and mature. I would like to welcome Ian Johnson as our new chairman, who has relevant, significant experience and will lead the company into its next phase of growth.”
Ian has spent his business career in life sciences. He was founder and CEO of Biotrace International, a leading provider of rapid microbial testing systems and reagents. Speaking about his appointment, Ian said: “I am sure the board would join me in thanking Mark for his stewardship to date and I look forward to building on his achievements as the company commences a new phase of development.”
www.biofortuna.com